Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > EBITDA Margin

Acadia Pharmaceutica EBITDA Margin Chart (ACAD)

Acadia Pharmaceutica annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Acadia Pharmaceutica EBITDA Margin for the quarter ending June 06, 2020 was $-39m a -20.39% increase of 8m year over year
  • Acadia Pharmaceutica EBITDA Margin for the last 12 months ending June 06, 2020 was $-59m a -43.17% increase of 26m year over year
  • Acadia Pharmaceutica Annual EBITDA Margin for 2019 was $-72m a -51.91% increase of 37m from 2018
  • Acadia Pharmaceutica Annual EBITDA Margin for 2018 was $-109m a -112.36% increase of 123m from 2017
  • Acadia Pharmaceutica Annual EBITDA Margin for 2017 was $-232m a -574.14% increase of 1,332m from 2016
Other Margins & Efficiency Metrics:
  • Acadia Pharmaceutica Return on Capital % for the quarter ending September 09, 2018 was -62.76 a 23.01% decrease of -14.44 year over year
  • Acadia Pharmaceutica Return on Equity % for the quarter ending September 09, 2018 was -101.83 a 24.07% decrease of -24.52 year over year
View Chart On Koyfin

Quarterly ACAD EBITDA Margin Data

06/2020$-39m
03/2020$-99m
12/2019$-57m
09/2019$-47m
06/2019$-68m
03/2019$-138m
12/2018$-112m
09/2018$-104m
06/2018$-111m
03/2018$-111m

Annual ACAD EBITDA Margin Data

2019$-72m
2018$-109m
2017$-232m
2016$-1,564m
2015$-253,057m
2014$-77,520m
2013$-3,338m
2012$-423m
2011$-1,092m
2010$37m